Pfizer raises offer for AstraZeneca
May 02, 2014 at 04:55 AM EDT
The U.S. drug maker has raised its offer for AstraZeneca to £50 a share, valuing its U.K. counterpart at £63 billion ($106.43 billion), in a fresh bid for AstraZeneca backing.